Elevated platelet counts and thrombocytosis in erythema nodosum leprosum

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 70, Issue 3, 2002, Pages 167-173

  Rea, Thomas H ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; THALIDOMIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HUMAN; MALE; SYMPTOMATOLOGY; THROMBOCYTE COUNT; THROMBOCYTOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ERYTHEMA NODOSUM; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS; MALE; MEXICO; MIDDLE AGED; PHILIPPINES; PLATELET COUNT; RETROSPECTIVE STUDIES; THALIDOMIDE; THROMBOCYTOSIS; UNITED STATES;

EID: 0036761042     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Baatout, S. Interleukin-6 and megakaryocytopoiesis: An update. Ann. Hematol. 73 (1966) 157-162.
2. Blay, J. Y., Rossi, J. F., Wydenes, J., Menetrier-Caux, C., Schemanns, S., Negrier, S., Philip, T. and Favrot, M. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int. J. Cancer 72 (1997) 424-430.
3. Brown, R. E., Shah, N. R., Lobel, J. S., George, B. A., Gaylord, H. and Simonich, W. L. Interleukin-6-associated laboratory parameters and immunochemistry in symptomatic stage A and B nodular sclerosing Hodgkin's disease in children. Ann. Clin. Lab. Sci. 27 (1997) 26-33.
4. Cerutti, A., Custodi, P., Mduranti, Cazzola, M. and Balduini, C. L. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant. Clin. Lab. Haematol. 21 (1999) 271-275.
5. de Benedetti, F., Massa, M., Robbioni, A., Burgio, G. R. and Martini, A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 34 (1991) 1158-1163.
6. Deshpande, S. V., Zawar, P. B., Chawhan, R. N., Sengupta, S. R. and Mehta, M. C. Alpha-1-antitrypsin in leprosy. Indian J. Lepr. 57 (1985) 767-772.
7. D'Hondt, V., Humblet, Y., Guillaume, T., Baatout, S., Chatelain, C., Berliere, M., Longuevllle, J., Feyens, A. M., De Greve, J., Van Oosterom, A., Von Graffenried, B., Donnez, J. and Symann, M. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: A multicentric placebo-controlled, randomized phase Ib study. Blood 85 (1995) 2347-2353.
8. Folman, C. C., Ooms, M., Kuenen, B. B., de Jong, S. M., Vet, R. J. W. M., de Haas, M. and Von dem Borne, E. G. K. The role of thrombopoietin bopoictin in post-operative thrombocytosis. Brit. J. Haematol. 114 (2001) 126-133.
9. Griesshammer, M., Bangerter, M., Sauer, T., Wennauer, R., Bergmann, L. and Heimpel, H. Aetiology and clinical significance of thrombocytosis: Analysis of 732 patients with an elevated platelet count. J. Int. Med. 245 (1999) 295-300.
10. Hastings, R. C., Trautman, J. R. and Enna, C. D. Thalidomide in the treatment of erythema nodosum leprosum. Clin. Pharmacol. Ther. 11 (1970) 481-487.
11. Heits, F., Stahl, M., Ludwig, D., Strange, E. F. and Jelkman, F. Elevated thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J. Interferon Cytokine Res. 19 (1999) 757-760.
12. Higashihara, M., Sunaga, S., Tange, T., Oohashi, H. and Kurokawa, K. Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis. Cancer 70 (1992) 2105-2108.
13. Hogevold, H. E., Lyberg, T., Kahler, H., Haug, E. and Reikeras, O. Changes in plasma IL-1 beta, TNF alpha and IL-6 after total hip replacement surgery in general or regional anesthesia. Cytokine 12 (2000) 1156-1159.
14. Hollen, C. W., Henthorn, J., Koziol, J. A. and Burstein, S. A. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Brit. J. Haematol. 79 (1991) 286-290.
15. Hussain, R., Lucas, S. B., Kifayet, A., Jamil, S., Raynes, J., Uqual, Z., Dockrell, H. M., Chiang, T. J. and McAdam, K. P. Clinical and histologic discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP. Int. J. Lepr. 63 (1995) 222-230.
16. Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P. and Burstein, S. A. Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci. USA 86 (1989) 5953-5957.
17. Ishiguro, A., Ishikita, T., Shimbo, T., Matsubara, K., Baba, K., Hayashi, Y., Naritaka, S. and Nakahata, T. Elevation of thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb. Haemost. 79 (1998) 1096-1100.
18. Jablons, D. M., Mule, J. J., McIntosh, J. K., Sehgal, P. B., May, L. T., Huang, C. M., Rosenberg, S. A. and Lotze, M. T. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. J. Immunol. 142 (1989) 1542-1547.
19. Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., Atkins, M. B., Mier, J. W. and Ting, H. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: Role in inflammatory thrombocytosis. Blood 98 (2001) 2720-2725.
20. Launois, R, Vandenbussehe, P., M'Bayame, N. N., Drowart, A., Van Vooren, J. P., Sarthou, J. L., Millan, J. and Huygen, K. Il-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy. Cell Immunol. 148 (1993) 283-290.
21. Moraes, M. O., Sarno, E. N., Almeida, A. S., Saraiva, B. C. C., Nery, J. A. C., Martins, R. C. L. and Sampaio, E. P. Cytokine mRNA expression in leprosy: A possible role for interferon-[gamma] and interleukin-12 in reactions (RR and ENL). Scand. J. Immunol. 50 (1999) 541-549.
22. Nieken, J., Mulder, N. H., Buter, J., Vellenga, E., Limburg, P. C., Piers, D. A. and de Vries, E. G. E. Recombinant human interleukin-6 induces a rapid and reversible anemia. Blood 86 (1995) 900-905.
23. Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T. and Yoshizaki, K. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95 (2000) 56-61.
24. Olencki, T., Finke, J., Tubbs, R., Elson, P., McLain, D., Herzog, P., Budd, G. T., Gunn, H. and Burkowski, R. M. Phase I trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects. J. Immunother. 23 (2000) 549-556.
25. Rea, T. H. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy. Int. J. Lepr. 69 (2001) 318-327.
26. Rea, T. H. and Sieling, P. A. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum. Int. J. Lepr. 66 (1998) 316-327.
27. Ridley, D. S., Histological classification and the immunological spectrum of leprosy. Bull. WHO 51 (1974) 451-465.
28. Sampaio, E. P., Kaplan, G., Marianda, A., Nery, J. A. C., Miguel, C. P., Viana. S. M. and Sarno, N. S. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum. J. Infect. Dis. 168 (1993) 408-414.
29. Sampaio, E. P., Moraes, M. O., Nery, J. A. C., Santos, A. R., Matos, H. C. and Sarno, E. N. Pentoxifylline decreased in vivo and in vitro tumor necrosis factor-alpha (TNF-[alpha]) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin. Exp. Immunol. 111 (1998) 300-308.
30. Sampaio, E. P., Moreira, A. L., Sarno, E. N., Malta, A. M. and Kaplan, G. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175 (1992) 1729-1737.
31. Sarno, E. N., Grau, G. E., Vieira, L. M. M. and Nery, J. A. Serum levels of tumor necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin. Exp. Immunol. 84 (1991) 103-108.
32. Sconocchia, G., Campagnano, L., Adorno, D., Iacona, A., Cococcetta, N. Y., Boffo, V., Amadori, S. and Casciani, C. U. CD44 ligation on peripheral blood polymoronuclear cells induces interleukin-6 production. Blood 97 (2001) 3621-3627.
33. Stahl, C., Zucker-Franklin, D., Evatt, B. L. and Winton, E. F. Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates. Blood 78 (1991) 1467-1475.
34. Swaak, A. J., Lienard, D., Schraford, T., Koops, K. H., Lejeune, F. J. and Eggermont, A. M. Effects of recombinant tumor necrosis factor (rTNFα) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF-alpha administration in isolated limb perfusions in cancer patients. Eur. J. Clin. Invest. 23 (1993) 812-818.
35. Tefferi, A., Ho, T. C., Ahmann, G. J., Katzmann, J. A. and Greipp, P. R. Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am. J. Med. 97 (1994) 374-378.
36. Weber, J., Gunn, H., Yang, J., Parkinson, D., Topalian, S., Schwartzentraber, D., Ettinghauser, S., Levitt, D. and Rosenberg, S. A. A phase I trial of intravenous interleukin-6 in patients with advanced cancer. J. Immunother. Emphasis Tumor Immunol. 15 (1994) 292-302.
37. Yamamura, M., Wang, X.-H., Ohmen, J. D., Uyemura, K., Rea, T. H., Bloom, B. R. and Modlin, R. L. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149 (1992) 1470-1475.
38. Yokoyama, A., Maruyama, M., Ito, M., Kohno, N., Hiwada, K. and Yano, S. Interleukin-6 activity in pleural effusions. Its diagnostic value and thrombopoietic activity. Chest 102 (1992) 1055-1059.
39. Yoshizaki, K., Nishimoto, N., Mihara, M. and Kishimoto, T. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody. Springer Semin. Immunopathol. 20 (1998) 247-259.